But companies like Pfizer (Inlyta for kidney cancer and Bosulif for leukemia), GSK (Mehibrix vaccine for Haemophilus flu), Merck (Zioptan for glaucoma) and Bayer (Stivarga for colorectal cancer) also are part of this surge in new drug approvals.

FORBES: Marcia Angell's Attacks on Pharma Have Lost all Credibility